510(k) device
Lympha Press Optimal Plus
Mego Afek AC , Ltd. · Sleeve, Limb, Compressible (JOW, Class II) · First FDA decision Oct 6, 2008, newest Feb 27, 2019LymphedemaPulmonary embolism and deep vein thrombosis
Last checked: Nov 19, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
3
510(k) pathway
Device trials
1
Naming "Lympha Press Optimal"
MAUDE reports
0
Brand "Lympha Press Optimal", since 2015
PubMed studies
0
Mentioning "Lympha Press Optimal"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing Lympha Press Optimal Plus
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 3 of 3 decisions filed under this name.
K182003 · Decided Feb 27, 2019 · 216 days after receipt
Device type: Sleeve, Limb, Compressible (JOW) · Cardiology
K170658 · Decided May 31, 2017 · 89 days after receipt
Device type: Sleeve, Limb, Compressible (JOW) · Cardiology
K082149 · Decided Oct 6, 2008 · 68 days after receipt
Device type: Sleeve, Limb, Compressible (JOW) · Cardiology
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
No Medicare coverage document has a title matching this device or device type. Many devices are paid under existing codes without one.
Clinical trials
Device studies on ClinicalTrials.gov that name "Lympha Press Optimal", any status and sponsor, newest update first.
Lympha PressAcademic, hospital or other
NCT06549738 · 46 participants · Start Aug 21, 2023 · Primary completion Nov 16, 2023
Device: Intermittent pneumatic compression therapy · For: Lipedema
Sites: Durham, North Carolina
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "Lympha Press Optimal", and for the whole product code for context.
This brand
0 reports: 0 malfunction, 0 injury, 0 death
Whole product code JOW
1,052 reports: 868 malfunction, 177 injury, 4 death
Newest reports for this brand
No MAUDE reports name this brand.
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
No recall in FDA's data is linked to these FDA numbers.
Published research
The most relevant PubMed records for "Lympha Press Optimal"[tiab]. The summary above synthesizes these.
No PubMed record mentions this device by name.
Other devices of this type
Also filed under product code JOW.
- Hygia Health Services Reprocessed Compression Sleeves / Foot CuffsHygia Health Services, Inc. · 510(k) 2009
- Reprocessed Compression SleevesAlliance Medical Corp. · 510(k) 2006
- Reprocessed Kendall SCD Express Compression SleevesCovidien · 510(k) 2017
- Kendall Scd 700 Sequential Compression ControllerCovidien · 510(k) 2013
- Vasculaire Compression SystemVenous Health Systems, Inc. · 510(k) 2013
- Aircast Venaflow Elite SystemDjo, LLC · 510(k) 2013
- DayspringKoya Medical, Inc. · 510(k) 2024
- medi pneumatic compression system (pcs)-genius (Model 652)Medi USA, LP · 510(k) 2022
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.